Major Depressive Disorder With Mixed Features - Extension
Public ClinicalTrials.gov record NCT01423253. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Lurasidone HCl is a compound that is a candidate for the treatment of major depressive with mixed features.This clinical study is designed to test how well Lurasidone works to treat major depressive disorder with mixed features over time.
Study identification
- NCT ID
- NCT01423253
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 48 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2011 (Type not available)
- Primary completion
- Oct 2013 (Actual)
- Completion
- Oct 2013 (Actual)
- Last update posted
- Apr 8, 2016
2011 – 2013
United States locations
- U.S. sites
- 17
- U.S. states
- 10
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham Psychiatry Pharmaceutical Studies, Inc | Birmingham | Alabama | 35226 | — |
| Synergy Clinical Research Center | Escondido | California | 92025 | — |
| Collaborative Neuro Science Network, Inc. | Garden Grove | California | 92845 | — |
| Stanford -VA Palo Alto Health Care System | Palo Alto | California | 94304 | — |
| Artemis Institute for Clinical Research | San Diego | California | 92123 | — |
| Florida Clinical Research Center, LLC | Sarasota | Florida | 34201 | — |
| Massachusetts General Hospital - Center for Anxiety and Traumatic Stress Disorders | Boston | Massachusetts | 02114 | — |
| St. Charles Psychiatric Associates/Midwest Research Group | Saint Charles | Missouri | 63301 | — |
| Village Clinical Research Inc. | New York | New York | 10003 | — |
| Finger Lakes Clinical Research | Rochester | New York | 14618 | — |
| Behavioral Medical Research of Staten Island | Staten Island | New York | 10305 | — |
| Psychiatry and Behavioral Sciences, Duke | Durham | North Carolina | 27705 | — |
| Midwest Clinical Research Center | Dayton | Ohio | 45408 | — |
| CRI Worldwide - Kirkbride | Philadelphia | Pennsylvania | 19139 | — |
| FutureSearch Trials of Dallas, LP | Dallas | Texas | 75231 | — |
| Dept. of Psychiatry, UT Southwestern Medical Center | Dallas | Texas | 75390-8849 | — |
| Grayline Clinical Drug Trials | Wichita Falls | Texas | 76309 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01423253, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2016 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01423253 live on ClinicalTrials.gov.